You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 138 No. 12, December 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Evidence-Based Dermatology: Research Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatologic Disorders
 •Wound Healing
 •Dermatology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Should Pentoxifylline Be Used as an Adjuvant for the Treatment of Venous Leg Ulcer?

David J. Margolis, MD,PhD

Arch Dermatol. 2002;138:1597-1598.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Commentary on: Pentoxifylline for the treatment of venous leg ulcers: a systematic review
Jull A, Waters J, Arroll B
Lancet. 2002;359:1550-1554

Question: What is the effect of pentoxifylline on the healing of venous leg ulcer?

Data Sources: The CENTRAL registers of the Cochrane Wounds Group and the Cochrane Peripheral Vascular Diseases Group. The authors also contacted Aventis Pharma France to obtain unpublished studies.

Studies: Studies were selected for inclusion if they were randomized clinical trials and reported either the percentage of change in ulcer area, percentage of ulcers healed, or percentage ulcer improvement of the patients' primary reference ulcer. Studies of all languages were included for analysis.

Data Synthesis: Cochrane software RevMan 4.1 (Cochrane Collaboration, Oxford, England) was used to estimate relative risks and 95% confidence intervals. The meta-estimates were also evaluated for study-based heterogeneity and for publication bias.

Results: The authors found 8 trials. . . . [Full Text of this Article]

Comment

Departments of Dermatology and Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.